Syros Pharmaceuticals, Inc. SYRS
Set alert
0.00 USD 0.00 0.00%
At close · Oct 29
0.11 +0.11 +26,700.00%
After hours · Oct 29, 4:00 PM ET
0.0005 Day range 0.0005
0.0001 52-week range 0.012
- YTD
- +14.29%
- 1 year
- 0.00%
- Open
- 0.0005
- Prev close
- 0.0004
- Mkt cap
- 10.73K
- Vol
- 904
- Avg vol
- 12.52K
- EPS
- -6.14
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0005
- High
- 0.0005
- Forward P/E
- -0.08
- Beta
- 1.59
- Short ratio
- 0.10
- Inst. own
- 75.59%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.20
- 200-d avg
- 3.65
- 1y target
- 1.00
2Y chart
Events in this range
- Oct 31, 2024Earnings: -0.68; estimate -0.76; surprise 10.53%
- Nov 1, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Nov 13, 2024Downgrade: Brookline Capital · Buy → Hold
- Nov 13, 2024Downgrade: JMP Securities · Market Outperform → Market Perform
- Nov 13, 2024Downgrade: HC Wainwright & Co. · Buy → Neutral
- Nov 13, 2024Downgrade: TD Cowen · Buy → Hold
Signals (136)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 22, 2026 | 1 week ago |
| MACD: Sell Signal | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 17, 2026 | 1 month ago |
| RSI: Overbought | Sep 16, 2026 | 1 month ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 31, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 24, 2026 | 2 months ago |
| SMA: Bearish | Aug 21, 2026 | 2 months ago |
| SMA: Bearish | Aug 21, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| SMA: Bearish | Aug 18, 2026 | 2 months ago |
| SMA: Bearish | Aug 18, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 17, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Aug 12, 2026 | 2 months ago |
| SMA: Bearish | Aug 12, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 11, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 6, 2026 | 2 months ago |
| SMA: Bearish | Aug 4, 2026 | 2 months ago |
| SMA: Bearish | Aug 4, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 30, 2026 | 3 months ago |
| SMA: Bullish | Jul 29, 2026 | 3 months ago |
| RSI: Overbought | Jul 29, 2026 | 3 months ago |
| SMA: Bearish | Jul 21, 2026 | 3 months ago |
| SMA: Bullish | Jul 20, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 9, 2026 | 3 months ago |
| SMA: Bearish | Jun 18, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 18, 2026 | 4 months ago |
| SMA: Bullish | Jun 17, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 17, 2026 | 4 months ago |
| SMA: Bearish | Jun 16, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 16, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 15, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 10, 2026 | 4 months ago |
| SMA: Bearish | Jun 8, 2026 | 4 months ago |
| SMA: Bullish | Jun 5, 2026 | 4 months ago |
| SMA: Bearish | Jun 4, 2026 | 5 months ago |
| SMA: Bullish | Jun 3, 2026 | 5 months ago |
| MACD: Buy Signal | Jun 3, 2026 | 5 months ago |
| SMA: Bearish | May 26, 2026 | 5 months ago |
| MACD: Sell Signal | May 26, 2026 | 5 months ago |
| SMA: Bullish | May 22, 2026 | 5 months ago |
| MACD: Buy Signal | May 22, 2026 | 5 months ago |
| MACD: Sell Signal | May 20, 2026 | 5 months ago |
| SMA: Bearish | May 19, 2026 | 5 months ago |
| SMA: Bullish | May 15, 2026 | 5 months ago |
| MACD: Buy Signal | May 15, 2026 | 5 months ago |
| MACD: Sell Signal | May 8, 2026 | 5 months ago |
| SMA: Bearish | May 7, 2026 | 5 months ago |
| SMA: Bullish | May 5, 2026 | 6 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
| SMA: Bullish | May 1, 2026 | 6 months ago |
| MACD: Buy Signal | May 1, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 29, 2026 | 6 months ago |
| SMA: Bearish | Apr 28, 2026 | 6 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
| SMA: Bearish | Apr 24, 2026 | 6 months ago |
| SMA: Bullish | Apr 22, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 22, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 21, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 16, 2026 | 6 months ago |
| SMA: Bearish | Apr 14, 2026 | 6 months ago |
| SMA: Bullish | Apr 10, 2026 | 6 months ago |
| SMA: Bearish | Apr 9, 2026 | 6 months ago |
| SMA: Bullish | Apr 8, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 8, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Mar 30, 2026 | 7 months ago |
| SMA: Bullish | Mar 26, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 24, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 19, 2026 | 7 months ago |
| SMA: Bearish | Mar 16, 2026 | 7 months ago |
| SMA: Bullish | Mar 13, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 13, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 11, 2026 | 7 months ago |
| SMA: Bearish | Mar 5, 2026 | 8 months ago |
| SMA: Bullish | Mar 4, 2026 | 8 months ago |
| MACD: Buy Signal | Mar 4, 2026 | 8 months ago |
| SMA: Bearish | Feb 11, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 11, 2026 | 8 months ago |
| SMA: Bullish | Feb 10, 2026 | 8 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| SMA: Bullish | Jan 29, 2026 | 9 months ago |
| SMA: Bearish | Jan 27, 2026 | 9 months ago |
| SMA: Bullish | Jan 26, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 26, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 14, 2026 | 9 months ago |
| SMA: Bearish | Jan 13, 2026 | 9 months ago |
| SMA: Bullish | Jan 12, 2026 | 9 months ago |
| SMA: Bearish | Jan 8, 2026 | 9 months ago |
| SMA: Bullish | Jan 6, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 6, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 5, 2026 | 10 months ago |
| SMA: Bearish | Dec 31, 2025 | 10 months ago |
| SMA: Bullish | Dec 30, 2025 | 10 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| SMA: Bullish | Dec 26, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 26, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 24, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 6, 2025 | 12 months ago |
| MACD: Sell Signal | Oct 17, 2025 | 1 year ago |
| SMA: Bearish | Oct 16, 2025 | 1 year ago |
| SMA: Bullish | Oct 3, 2025 | 1 year ago |
| SMA: Bearish | Sep 23, 2025 | 1 year ago |
| SMA: Bullish | Sep 22, 2025 | 1 year ago |
| SMA: Bearish | Aug 25, 2025 | 1 year ago |
| SMA: Bullish | Aug 22, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 12, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 29, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 23, 2025 | 1 year ago |
| SMA: Bearish | Jul 15, 2025 | 1 year ago |
| SMA: Bullish | Jul 14, 2025 | 1 year ago |
| RSI: Oversold | Jul 9, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 8, 2025 | 1 year ago |
| SMA: Bearish | Jun 30, 2025 | 1 year ago |
| SMA: Bullish | Jun 27, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 17, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 5, 2025 | 1 year ago |
| SMA: Bearish | Jun 3, 2025 | 1 year ago |
| SMA: Bullish | Jun 2, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 4, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 25, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 11, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 3, 2025 | 1 year ago |
| RSI: Oversold | Mar 3, 2025 | 1 year ago |
| RSI: Oversold | Dec 31, 2024 | 1 year ago |
Key statistics
- Market cap
- 5.47M
- Enterprise value
- 7.32M
- Trailing P/E
- 0.00
- Forward P/E
- -0.08
- PEG ratio
- 0.00
- Price / sales
- 14.17
- Price / book
- 0.00
- EPS (TTM)
- -3.07
- Beta
- 1.59
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 386.00K
- Revenue growth
- 0.00%
- Free cash flow
- -57.94M
- Total cash
- 58.27M
- Total debt
- 60.23M
- Return on equity
- -776.96%
- Shares outstanding
- 26.83M
- Short % of float
- 9.06%
- 50-day average
- 1.20
- 200-day average
- 3.65
Analyst view
Consensus: none
Price target (mean) 1.00
Ratings (0m) 4 0 buy · 4 hold · 0 sell
- Strong buy0
- Buy0
- Hold4
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.70667.
Financials — quick view
SYRS Revenue — quarterly 0
SYRS Net income — quarterly -6.40M
SYRS EPS — quarterly -0.16
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 31, 2024 | Sep 1, 2024 | -0.76 | -0.68 | +0.08 | +10.53% |
| Jul 31, 2024 | Jun 1, 2024 | -0.79 | -0.70 | +0.09 | +11.39% |
| May 14, 2024 | Mar 1, 2024 | -0.89 | -0.79 | +0.10 | +11.24% |
| Mar 27, 2024 | Dec 1, 2023 | -1.23 | -1.19 | +0.04 | +3.25% |
| Nov 14, 2023 | Sep 1, 2023 | -1.12 | -1.35 | -0.23 | -20.54% |
| Aug 8, 2023 | Jun 1, 2023 | -1.11 | -1.30 | -0.19 | -17.12% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 13, 2024 | TD Cowen | down | Buy | Hold |
| Nov 13, 2024 | HC Wainwright & Co. | down | Buy | Neutral |
| Nov 13, 2024 | JMP Securities | down | Market Outperform | Market Perform |
| Nov 13, 2024 | Brookline Capital | down | Buy | Hold |
| Nov 1, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Aug 13, 2024 | Piper Sandler | reit | Overweight | Overweight |
About Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome and Phase II clinical trial for patients with acute myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide for treating patients with acute promyelocytic leukemia; and SY-5609, a cyclin-dependent kinase 7 inhibitor, which is in a Phase I clinical trial in patients with select advanced solid tumors. The company was formerly known as LS22, Inc. and changed its name to Syros Pharmaceuticals, Inc. in August 2012. Syros Pharmaceuticals, Inc. was incorporated in 2011 and is headquartered in Cambridge, Massachusetts.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- syros.com
News
- Critical Analysis: Syros Pharmaceuticals (NASDAQ:SYRS) & ADVANZ PHARMA (OTCMKTS:CXRXF)
- Cyclacel Pharmaceuticals (NASDAQ:BGMS) vs. Syros Pharmaceuticals (NASDAQ:SYRS) Head to Head Analysis
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- 12 Health Care Stocks Moving In Friday's Intraday Session
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- US Stocks Likely To Open Higher As Wall Street Watches Trump Tariff Talks: 'March, April, May Tend To Be Solid Months In Post-Election Years,' Says Expert
- Syros Announces Voluntary Delisting from Nasdaq and SEC Deregistration
- Syros Stock Plunges as Lead Cancer Study Fails to Meet Primary Goal
Your note
Sign in to keep a note on SYRS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AKKARAJU SRINIVAS | Director | Conversion of Exercise of derivative security | Sep 15, 2024 | 9,333 |
| CHEE CONLEY | Chief Executive Officer | Sale | Nov 17, 2024 | 0 |
| FANUCCI MARSHA H | Director | Stock Award(Grant) | Jun 4, 2024 | 16,000 |
| HAAS JASON | Chief Financial Officer | Sale | Nov 17, 2024 | 0 |
| QUIRK GERALD E. | Officer | Sale | Nov 18, 2024 | 0 |
| ROTH DAVID A M.D. | Officer | Sale | Nov 17, 2024 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 10.25% | 2,750,151 | 560.75K | Sep 29, 2024 |
| Siren, L.L.C. | 9.64% | 2,587,372 | 527.57K | Sep 29, 2024 |
| Adage Capital Partners GP L.L.C. | 7.72% | 2,071,914 | 422.46K | Sep 29, 2024 |
| Samsara BioCapital, LLC | 6.66% | 1,786,427 | 364.25K | Sep 29, 2024 |
| Point72 Asset Management, L.P. | 5.49% | 1,471,771 | 300.09K | Sep 29, 2024 |
| Flagship Pioneering Inc. | 4.82% | 1,293,849 | 263.81K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.44% | 654,183 | 133.39K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.96% | 257,635 | 52.53K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.37% | 100,122 | 20.41K | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.21% | 56,602 | 11.54K | Oct 30, 2024 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.19% | 50,670 | 10.33K | Sep 29, 2024 |
| Fidelity Total Market Index Fund | 0.15% | 39,831 | 8.12K | Oct 30, 2024 |